Zomedica Corp. Quarterly Cost of Revenue in USD from Q2 2020 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Zomedica Corp. quarterly/annual Cost of Revenue history and growth rate from Q2 2020 to Q2 2024.
- Zomedica Corp. Cost of Revenue for the quarter ending June 30, 2024 was $1.77M, a 10.3% decline year-over-year.
- Zomedica Corp. Cost of Revenue for the twelve months ending June 30, 2024 was $1.94M, a 71.6% decline year-over-year.
- Zomedica Corp. annual Cost of Revenue for 2023 was $1.65M, a 69.8% decline from 2022.
- Zomedica Corp. annual Cost of Revenue for 2022 was $5.46M, a 406% increase from 2021.
- Zomedica Corp. annual Cost of Revenue for 2021 was $1.08M.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)